Delivery Order SPE2DB20D9329-SPE2DB24FZK33

Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,892.90, is for the procurement of Nucala 100 mg/mL auto-injectors to support the medical supply needs of military health facilities. This award is part of a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the agency to...
This federal contract award, valued at $3,785.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Nucala 100 mg/mL auto-injectors, a specialized biologic medication. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,678.70 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,929.00 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,571.60 firm fixed-price delivery order covers the procurement of Nucala 100 mg/mL auto-injectors to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,678.70 firm fixed-price delivery order is for the supply of Nucala 100 mg/ml auto-injectors. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,714.80 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors to support the medical needs of military healthcare facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,892.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Nucala 100 mg/mL auto-injector medication, which is likely to support the medical needs of military personnel and their dependents. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,571.60 firm fixed-price delivery order is for the supply of NUCALA 100 MG/ML AUTO-INJECTOR pharmaceutical products. The award is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,678.70 firm fixed-price delivery order is for the supply of Nucala 100 mg/ml auto-injectors. The contract is part of a larger indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December...
  • SPE2DB20D9329
    Indefinite Delivery Contract
  • SPE2DB20D9329-SPE2DB24FZK33
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,678.70 firm fixed-price delivery order is for the supply of Nucala 100 mg/ml auto-injectors.

The award is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This single-award IDC covers a vast array of pharmaceutical products, from common medications to specialized drugs and medical supplies. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of the Department of Defense healthcare system.

The contract has no set-aside designation. DMS Pharmaceutical Group's status as a woman-owned small business has enabled it to secure direct awards for pharmaceutical prime vendor programs supporting military medical facilities globally.

Generated 1/9/25, 9:08 AM